Filing Details
- Accession Number:
- 0001415889-22-011489
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-17 16:05:39
- Reporting Period:
- 2022-11-15
- Accepted Time:
- 2022-11-17 16:05:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | NASD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017832 | P Martin Sutter | 22 Cherry Hill Drive Danvers MA 01923 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Disposition | 2022-11-15 | 1,133 | $374.18 | 122,237 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-11-15 | 867 | $374.92 | 121,370 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-11-16 | 1,859 | $374.66 | 119,511 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2022-11-16 | 141 | $375.56 | 119,370 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the sale price of the transactions on the reported date at $374.1828. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $374.9239. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $374.6617. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the sale price of the transactions on the reported date at $375.5611. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
